Dr. Christian August Engell, MD

Dr. Engell practices at Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health.

Dr. Engell's NPI, 1831374305, was assigned on January 3, 2008. Dr. Engell graduated from University of Copenhagen Medical School in 2002. Dr. Engell holds New Jersey license 25MA08368800.

Dr. Engell's primary practice is Newark Beth Israel Medical Center, at 201 Lyons Ave, Newark, NJ 07112 in Essex County. The practice phone is (973) 926-7000.

Dr. Engell's primary practice is Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Engell to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Engell practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Engell's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Engell is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Engell's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists hiv/aids among the conditions Dr. Engell treats.

CMS data shows 151 Medicare services from Dr. Engell across 4 procedure codes in 2024, for 90 Medicare patients. Medicare paid $11,473 for them.

CMS counts 90 Medicare patients who saw Dr. Engell in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 3.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Engell's median patient age at 59, with 39% women.

In 2024, Dr. Engell wrote 755 Medicare Part D claims for 140 patients. CMS names the drug for 672 of them, across 16 drugs with 11 or more claims each, at $2,386,160 in total drug cost. In 2023, CMS named 416 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Engell for performance year 2024, reported through an alternative payment model (APM). Dr. Engell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Engell, published from 2011 to 2020. The most frequent topics are Intensive Care Units. Dr. Engell's most frequent co-authors are Charles Stewart Cathcart, MD, Neha S. Dangayach, MD and Harpreet Singh Grewal, MD.

CMS Open Payments shows 344 general payments to Dr. Engell from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Theravance Biopharma, Inc. paid the most, $3,497.

Dr. Engell graduated from University of Copenhagen Medical School in 2002.

Dr. Engell is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.